Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025
No matter the market environment, you’ll always find entertainment in the biotech space.
Genelux Corp (GNLX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Alyeska Investment Group Anand Parekh | 285,000 | $1,197,000 | 0% | |
| 2. | Renaissance Technologies Jim Simons | 62,900 | $264,180 | +178% | 0% |
| 3. | Citadel Investment Group Ken Griffin | 34,243 | $143,821 | 0% | |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 33,746 | $141,733 | +5% | 0% |
| 5. | 20,300 | $85,260 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 6,250 | $0.00 | 9,710 | 2024-05-29 | Filing | |
| $0.00 | 6,250 | $0.00 | 13,170 | 2024-05-29 | Filing | |
| $0.00 | 2,500 | $0.00 | 465,960 | 2024-05-29 | Filing | |
| $0.00 | 8,000 | $0.00 | 12,460 | 2024-05-29 | Filing | |
| $0.00 | 2,500 | $0.00 | 2,500 | 2024-05-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.00 | 10,000 | $50,008.00 | 492,784 | 2025-12-01 | Filing | |
| $2.92 | 4,475 | $13,067.00 | 47,621 | 2025-05-12 | Filing | |
| $2.92 | 10,764 | $31,430.88 | 191,447 | 2025-05-12 | Filing | |
| $2.92 | 5,579 | $16,290.68 | 47,640 | 2025-05-12 | Filing | |
| $2.92 | 4,737 | $13,832.04 | 52,266 | 2025-05-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,844,099 | $7,745,216 | 3.61% | |
| 2. | 1,419,381 | $5,961,400 | 0% | |
| 3. | 714,000 | $2,998,800 | 0.58% | |
| 4. | 379,888 | $1,595,529 | 0% | |
| 5. | 353,840 | $1,486,536 | 0% |
News See All
10 Recent IPOs in 2023 to Consider
Most companies don't list their shares on the stock market.